- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01683799
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
September 28, 2016 updated by: Kathi Heffner, University of Rochester
Slow Wave Sleep and Inflammatory Processes in Pain
The purpose if the study is to determine whether improving sleep, especially slow wave or "deep" sleep, in older adults with osteoarthritis (OA) and insomnia reduces pain sensitivity and inflammatory responses to pain, and improves OA-related pain.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 50-75 years of age (for women, post-menopausal)
- Kellgren-Lawrence grade II radiographic evidence of OA affecting one or both knees
- knee pain on most days for ≥ 6 months
- self-reported disability due to knee pain for ≥ 2 of the following: walking, kneeling, ascending or descending stairs, or performing daily activities
- willing and able to avoid all prescription and non-prescription, non-opiate pain medication for 48 hours prior to testing and all narcotic pain medication for 2 weeks prior to testing
- meets research diagnostic criteria for sleep maintenance insomnia
Exclusion Criteria:
- health conditions with immunological components or undergoing or taking immunosuppressive therapies
- conditions contraindicated for or potentially limiting ability to conduct NFR and/or cold pressor test (e.g. Raynaud's syndrome; seizures; prior MI; respiratory conditions; leg/hip nerve damage; BMI ≥ 32)
- sleep disorders other than insomnia
- dementia or cognitive impairment
- history of schizophrenia or bipolar I disorder; current or recent history (within 3 months) of major psychiatric disorders
- current depressive symptomatology or current suicidality
- active substance dependence
- untreated hypertension
- use of antidepressants (stable use for 3 months okay), antipsychotics, mood stabilizers, sedative-hypnotics, opiate analgesics
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: Insomnia treatment
Cognitive Behavioral Therapy for Insomnia
|
6-week behavioral treatment for insomnia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from baseline in minutes of time in slow wave sleep
Time Frame: baseline and 10 weeks
|
baseline and 10 weeks
|
|
Change from baseline in relative power of delta EEG activity to index slow wave sleep activity
Time Frame: baseline and 10 weeks
|
baseline and 10 weeks
|
|
Change from baseline in nociception flexion reflex threshold
Time Frame: baseline and 10 weeks
|
baseline and 10 weeks
|
|
Change from baseline in electrocutaneous pain threshold
Time Frame: baseline and 10 weeks
|
baseline and 10 weeks
|
|
Change from baseline in inflammatory cytokine responses to pain
Time Frame: baseline and 10 weeks
|
baseline and 10 weeks
|
|
Change from baseline in Western Ontario and McMaster University OA Index
Time Frame: baseline and 10 weeks
|
baseline and 10 weeks
|
|
Change from baseline in Knee Pain Scale score
Time Frame: baseline and 10 weeks
|
baseline and 10 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Wilfred Pigeon, PhD, University of Rochester
- Principal Investigator: Kathi L. Heffner, PhD, University of Rochester
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
July 1, 2015
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
September 7, 2012
First Submitted That Met QC Criteria
September 7, 2012
First Posted (Estimate)
September 12, 2012
Study Record Updates
Last Update Posted (Estimate)
September 30, 2016
Last Update Submitted That Met QC Criteria
September 28, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RSRB00044088
- R21AG041942-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteNot yet recruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
-
Leiden University Medical CenterCompleted
-
Shanghai Haiyan Pharmaceutical Technology Co.,...Active, not recruiting
-
Weill Medical College of Cornell UniversityMARPACCompleted
-
Regenstrief Institute, Inc.Merck Sharp & Dohme LLC; National Sleep FoundationUnknownInsomniaUnited States
-
Posit Science CorporationUniversity of California, San FranciscoCompleted
-
University of UtahNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Minneapolis Veterans Affairs Medical CenterWithdrawn
Clinical Trials on Cognitive Behavioral Therapy for Insomnia
-
University of Kansas Medical CenterCompletedMultiple SclerosisUnited States
-
University of ArizonaCompletedSleep Initiation and Maintenance DisordersUnited States
-
Tel Aviv UniversityIsrael Science FoundationRecruiting
-
The University of Texas Health Science Center at...Congressionally Directed Medical Research Programs; Hope Health Research InstituteRecruitingInsomnia | Mild Traumatic Brain InjuryUnited States
-
Stanford UniversityNational Institute of Nursing Research (NINR)Completed
-
Southeast Louisiana Veterans Health Care SystemVISN 16 Mental Illness Research, Education and Clinical Center (MIRECC)CompletedSleep Initiation and Maintenance DisordersUnited States
-
University of RochesterNational Institute of Nursing Research (NINR)CompletedDepression | Sleep | Stress Disorders, Post-TraumaticUnited States
-
Dartmouth-Hitchcock Medical CenterCrohn's and Colitis FoundationCompletedPain | Inflammation | Insomnia | Sleep Disturbance | Crohn DiseaseUnited States
-
Balearic Islands Health Service (Ibsalut)Completed
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingGambling Disorder TreatmentFrance